leisure time -WSS

leisure time

author：focus 2025-10-01 04:13:26 - browse：923

In 2020, James Sulzer’s personal and professional lives suddenly intersected after his then 4-year-old daughter sustained a devastating injury. As a researcher and associate professor in physical medicine and rehabilitation at Case Western Reserve University, Sulzer has spent his life tinkering with tools that help patients with neurological conditions. But after his child’s traumatic brain injury, Sulzer’s eyes were opened to how much his field was missing about the real experiences of families dealing with recovery.

In this week’s episode, Sulzer speaks with host Torie Bosch about the importance of centering patients in research and treatment. “For some reason in rehabilitation research, we’ve kind of lost that ethos,” Sulzer says. “It hasn’t become part of our DNA anymore.”

Read Sulzer’s full essay: “After 20 years in rehabilitation research, my young daughter’s traumatic brain injury transformed my mind and my career.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： What does generative AI mean for health care? We asked experts
Next article： Diversity in medical illustrations gets boost from Chidiebere Ibe

WSS

Readout LOUD podcast: possible new ALS drug, artificial wombs

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Why more medical students aren't specializing in primary care

Microbiome research is starting to find links to chronic diseases

What Congress can do to address the rural doctor shortage

Senate HELP committee spars over health care workforce policies

knowledge

leisure time

hotspot

At least 13 dead in Texas as scorching temps continue

Readout LOUD podcast: possible new ALS drug, artificial wombs

BioMarin wins approval for gene therapy to treat hemophilia A

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Drug repurposing or repositioning? The language matters

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Radiation, mainstay of cancer treatment, begins a fade

Medical records are filled with copy

How Vertex's cystic fibrosis drug is changing patients' lives

leisure time

EpiPen alternative approval delay highlights citizen petition issue

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

NYU Langone launches private ChatGPT for its health care data

What do new weight loss drugs mean for bariatric surgery?

Senators: Long

explore

Wikipedia

knowledge

focus